news roundup
VirTrial has announced an alliance with Pratia, a network of clinical research centers in Europe. The alliance has allowed all Pratia research centers to complete VirTrial's Virtual Trial Capable training, making them trained and certified as Virtual Trial Capable and prepared to conduct decentralized clinical trials (DCT).
Datacubed Health has launched Linkt Location, a geofencing app that is installed on a participant's phone and can alert study managers when a participant has entered hospitals, doctors' offices, and other healthcare facilities. This helps pharmaceutical companies, CROs, and other healthcare providers to detect health events that often go undetected with existing data capture methods. Linkt Location joins Datacubed's eCOA, behavior, and cognition module solutions.
|
|
| advertisement
Trends and Insights for Your Oncology Trial:
Tuesday, November 12, 2019 at 10am EST
 Register Now
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
|
The Pulmonary Fibrosis Foundation (PFF) launched a new PF Drug Development Pipeline tool to help the pulmonary fibrosis (PF) community search for different treatment options currently in development for interstitial lung diseases. Building off PFF's Clinical Trials Education Center, the Pipeline tool features news about recent drug and study announcements, as well as links to its Clinical Trial Finder page and Drug Development Pipeline Glossary. The PFF connects researchers to medical information from more than 2,000 patient volunteers through its PFF Patient Registry.
| advertisement
Launching Medical Devices in the Japanese Market
- How to navigate regulatory and reimbursement approval
Thursday, October 31, 2019 at 11am EDT
 Register Now |
Articles
The precision medicine market is expected to exceed $96 billion by 2024, with the oncology segment of the market leading the way. Patients, providers, and advocacy groups are pushing for innovation, but precision oncology is still in its infancy and significant challenges remain.
| advertisement
Will Decentralized Clinical Trials Compound Patient and Data Quality Risks?
Tuesday, October 29, 2019 at 1pm EDT | 12pm CDT| 10am PDT
 Register Now |
Over the last 15 years, the addition of novel therapies for prostate cancer have made a significant positive impact for patients. Essentially all the agents detailed have demonstrated an improvement in overall survival, progression free survival, or both. An example includes the greater than one-year overall survival improvement in castrate-sensitive metastatic prostate cancer patients when they receive docetaxel chemotherapy.
|
|
| advertisement
GrantPlan: Create Grant Budgets with Confidence and Accuracy
 ON DEMAND |
|
| advertisement
Begin with the End in Mind: The Strategic Benefit of Coordinating Site Budgeting, Contracting, & Payments
 On Demand |
Blog Posts
In this interview, Vimal Mehta, CEO, and Vince O'Neill, CMO, at BioXcel Therapeutics discuss how they are actively using AI to discover advanced therapies in CNS and oncology.
| advertisement
How AI/ML and advanced techniques are enhancing clinical development
Lessons learned from use in study design, patient and site ID, safety, and risk-based monitoring
 On Demand |
Slovenia's Minister of Health Aleš Šabeder, wants equity in health, “not only as a value but also a fact,” and makes the case that, "investments in the health system, including in preventive services and in reducing health inequalities, contribute to growth, sustainable development and societal well-being."
| advertisement
Successful Early Phase Drug Development of mAb Drugs
 On Demand |
Often looking at clinical trials trends, there is a tendency to forget how the ecosystem must adapt to those changes. Speficially, in the area of randomization and trial supply, how patients receive their trial drugs through automation can be overlooked. Later this month, CBI is holding its 2-day conference to address how RTSM, IWRS, IRT can influence trends including complex trial designs, direct-to-patient or decentralized trials, study startup, blockchain and more.
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
